Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.667 USD | +1.34% |
|
+4.19% | +35.51% |
| Market Cap | 46.18M 40.26M 37.29M 34.91M 65.47M 4.36B 65.86M 442M 171M 2.14B 173M 170M 7.45B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 44.86M 39.11M 36.22M 33.91M 63.59M 4.23B 63.98M 430M 167M 2.08B 168M 165M 7.23B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.34% | ||
| 1 week | +4.19% | ||
| Current month | -1.94% | ||
| 1 month | -7.39% | ||
| 3 months | +1.03% | ||
| 6 months | +38.92% | ||
| Current year | +35.51% |
| 1 week | 1.57 |  | 1.71 |
| 1 month | 1.57 | | 1.82 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.7 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.51 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-20 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 01-20 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 01/02/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.34% | +4.19% | +116.49% | +37.77% | 46.18M | |
| +2.19% | +9.12% | +35.34% | +360.52% | 33.14B | |
| -1.44% | -3.88% | -2.13% | +9.20% | 20.98B | |
| +1.06% | -0.74% | -23.68% | -43.35% | 6.95B | |
| +1.74% | -5.24% | -5.92% | +71.26% | 4.23B | |
| -1.63% | +2.14% | +13.61% | +54.24% | 2.9B | |
| +4.59% | -1.52% | -8.41% | +779.43% | 1.75B | |
| +0.37% | -2.73% | -9.60% | -67.13% | 1.68B | |
| +0.39% | -7.83% | +32.08% | -30.59% | 1.65B | |
| -1.84% | -1.65% | +10.84% | -4.17% | 1.58B | |
| Average | +0.68% | -1.87% | +15.86% | +116.72% | 7.49B | |
| Weighted average by Cap. | +0.79% | +0.70% | +13.63% | +180.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.91M 37.89M 35.47M 66.53M 4.43B 66.93M 450M 174M 2.18B 176M 172M 7.57B | 38.73M 33.77M 31.27M 29.28M 54.91M 3.65B 55.24M 371M 144M 1.8B 145M 142M 6.25B |
| Net income | 6.7M 5.84M 5.41M 5.07M 9.5M 632M 9.56M 64.2M 24.88M 311M 25.16M 24.62M 1.08B | 24.58M 21.43M 19.84M 18.58M 34.84M 2.32B 35.05M 235M 91.24M 1.14B 92.25M 90.27M 3.96B |
| Net Debt | 4.4M 3.83M 3.55M 3.32M 6.23M 415M 6.27M 42.1M 16.32M 204M 16.5M 16.14M 709M | -1.32M -1.15M -1.07M -999K -1.87M -125M -1.89M -12.66M -4.91M -61.4M -4.96M -4.86M -213M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 1.667 $ | +1.34% | 928 |
| 17/06/26 | 1.645 $ | +4.78% | 205 |
| 16/06/26 | 1.570 $ | -0.32% | 12,108 |
| 15/06/26 | 1.575 $ | -1.56% | 2,606 |
| 12/06/26 | 1.600 $ | -3.03% | 4,644 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
